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Functional counterparts of mammalian protein kinases PDK1
and SGK in budding yeast
Antonio Casamayor*, Pamela D. Torrance†, Takayasu Kobayashi*, 
Jeremy Thorner† and Dario R. Alessi*
Background: In animal cells, recruitment of phosphatidylinositol 3-kinase by
growth factor receptors generates 3-phosphoinositides, which stimulate
3-phosphoinositide-dependent protein kinase-1 (PDK1). Activated PDK1 then
phosphorylates and activates downstream protein kinases, including protein
kinase B (PKB)/c-Akt, p70 S6 kinase, PKC isoforms, and serum- and
glucocorticoid-inducible kinase (SGK), thereby eliciting physiological responses. 
Results: We found that two previously uncharacterised genes of
Saccharomyces cerevisiae, which we term PKH1 and PKH2, encode protein
kinases with catalytic domains closely resembling those of human and
Drosophila PDK1. Both Pkh1 and Pkh2 were essential for cell viability.
Expression of human PDK1 in otherwise inviable pkh1∆ pkh2∆ cells permitted
growth. In addition, the yeast YPK1 and YKR2 genes were found to encode
protein kinases each with a catalytic domain closely resembling that of SGK;
both Ypk1 and Ykr2 were also essential for viability. Otherwise inviable ypk1∆
ykr2∆ cells were fully rescued by expression of rat SGK, but not mouse PKB or
rat p70 S6 kinase. Purified Pkh1 activated mammalian SGK and PKBα in vitro
by phosphorylating the same residue as PDK1. Pkh1 activated purified Ypk1 by
phosphorylating the equivalent residue (Thr504) and was required for maximal
Ypk1 phosphorylation in vivo. Unlike PKB, activation of Ypk1 and SGK by Pkh1
did not require phosphatidylinositol 3,4,5-trisphosphate, consistent with the
absence of pleckstrin homology domains in these proteins. The phosphorylation
consensus sequence for Ypk1 was similar to that for PKBα and SGK.
Conclusions: Pkh1 and Pkh2 function similarly to PDK1, and Ypk1 and Ykr2 to
SGK. As in animal cells, these two groups of yeast kinases constitute two tiers of
a signalling cascade required for yeast cell growth.
Background
Receptor-mediated activation of phosphatidylinositol (PI)
3-kinase in animal cells stimulates a recently identified
3-phosphoinositide-dependent protein kinase, termed
PDK1 (for review, see [1,2]). This enzyme was first identi-
fied [3,4] by its ability to activate protein kinase B (PKB)
[5], also called RAC (for related to PKA and PKC) kinase
[6], and known also as the cellular homologue (c-Akt) of a
retroviral oncoprotein, v-Akt [7]. PDK1 activates all known
isoforms of PKB/c-Akt by phosphorylating a threonine
residue in a conserved sequence motif (Thr–Phe–Cys–
Gly–Thr–X–Glu–Tyr, where the bold Thr represents the
phosphorylated residue and X represents any amino acid)
located within the ‘activation loop’ of the catalytic domain,
situated between the conserved protein kinase subdomains
VII and VIII [8]. This residue corresponds to Thr308 in
PKBα, Thr309 in PKBβ, and Thr305 in PKBγ [9].
PDK1 is a monomeric 63 kDa enzyme comprising an
amino-terminal catalytic domain and a carboxy-terminal
extension containing a pleckstrin homology (PH) domain
that binds PI 3,4,5-trisphosphate (PI(3,4,5)P3) or PI 3,4-bis-
phosphate (PI(3,4)P2) or, more weakly, PI(4,5)P2 [10,11].
PI(3,4,5)P3 is generated from PI(4,5)P2 by PI 3-kinase, and
can be converted to PI(3,4)P2 or PI(4,5)P2 by different
classes of 5- and 3-phosphoinositide phosphatases [12,13].
Like PDK1, PKB contains a PH domain specific for
PI(3,4,5)P3 and PI(3,4)P2 [14,15], although in PKB it is
located at the amino terminus. The PH domain of PKB
blocks access to the phosphorylation site in the carboxy-
terminal catalytic domain and this inhibition is relieved
upon binding of lipids to the PH domain. Correspondingly,
PKB is only activated by PDK1 in vitro in the presence of
lipid vesicles containing PI(3,4,5)P3 or PI(3,4)P2 (for
review, see [16,17]).
Since its discovery, PDK1 has been shown to phosphory-
late other classes of protein kinases in vitro and cumulative
evidence indicates that PDK1 is responsible for activating
these enzymes in vivo. Thus, PDK1 may serve as a central
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integrator for signalling events from receptors that stimu-
late PI 3-kinase. Additional PDK1 targets elucidated to
date include: p70 S6 kinase [18,19]; at least two PKC iso-
forms [20,21]; the catalytic subunit of cAMP-dependent
protein kinase (PKA) [22]; and, most recently, serum- and
glucocorticoid-inducible kinase (SGK) [23]. All of these
enzymes contain in their activation loop the conserved
phosphorylation sequence first found in PKB/c-Akt and
are phosphorylated by PDK1 at the corresponding threo-
nine residue. Hence, this motif has been termed the
PDK1 site. Full activation of PKB, however, also requires
phosphorylation at a second site, Ser473, situated in a
hydrophobic motif (Phe–X–X–Ar–Ser/Thr–Ar, where the
bold residue is the phosphorylated amino acid and Ar rep-
resents an aromatic residue) towards the carboxyl terminus
[24]. Phosphorylation at this second site in PKB in vivo is
prevented by inhibitors of PI 3-kinase [24]. This second
motif is also conserved in the other PDK1-activated
protein kinases listed above (except for PKA) and lies at a
roughly equivalent position carboxy-terminal to the PDK1
site [20,25,26]. Neither purified nor recombinant PDK1
phosphorylates this second site [3,27], suggesting that this
event requires either modification of the activity of PDK1
or a distinct enzyme, provisionally termed PDK2. 
If PDK1 and its target protein kinases perform functions
vital to signalling in all eukaryotic cells, then these mole-
cules should be evolutionarily conserved. We have shown
previously that a PDK1-like enzyme is present in the fruit
fly, Drosophila melanogaster [27]. Here, we demonstrate both
genetically in vivo and biochemically in vitro that PDK1-
like and SGK-like protein kinases are present in budding
yeast, Saccharomyces cerevisiae, and that these kinases are
essential for cell growth and viability. Additional findings
suggest that, as in animal cells, the PDK1-like enzymes are
likely to play a role in activating other classes of protein
kinases, in addition to the SGK-like enzymes.
Results
PKH1 and PKH2 encode homologues of mammalian PDK1 
The S. cerevisiae genome contains two, previously unchar-
acterised, open reading frames (YDR490c and YOL100w)
that encode protein kinases whose catalytic domains are
72% identical and share 50% identity with either human or
Drosophila PDK1 (Figure 1a). These loci were designated
PKH1 and PKH2, respectively (for PKB-activating kinase
homologues 1 and 2). PKH1 is located on the right arm of
chromosome IV [28] and encodes a 766-residue protein
(86 kDa); PKH2 is situated on the left arm of chromosome
XV [29] and encodes a 1,081-residue protein (121 kDa).
Pkh1 and Pkh2 contain both amino-terminal and carboxy-
terminal extensions to the catalytic domain (Figure 1b)
and are much less similar to each other (only 27% identity)
in these regions. These regions display no apparent simi-
larity with the non-catalytic regions of PDK1 or with other
known proteins. In particular, Pkh1 and Pkh2 lack any
obvious PH domain, unlike human and Drosophila PDK1
which have a PH domain at their carboxyl terminus. 
PKH1 and PKH2 are essential genes that are functionally
redundant 
To determine whether the genes PKH1 and PKH2 encode
expressed proteins, the effect of loss-of-function muta-
tions in these loci was examined. Each open reading frame
was deleted and replaced with a selectable marker (TRP1
for PKH1 and HIS3 for PKH2). The resulting alleles,
pkh1∆::TRP1 and pkh2∆::HIS3, were used to replace the
normal chromosomal loci by homologous recombination.
Both a haploid pkh1∆::TRP1 mutant strain (AC301) and a
haploid pkh2∆::HIS3 mutant strain (AC303) grew normally
and indistinguishably from congenic PKH1+ and PKH2+
haploids isolated from the same tetrad. Also, pkh1∆ and
pkh2∆ single mutants displayed no apparent phenotype
when challenged by high concentrations of salt or caffeine,
various carbon sources, different temperatures, or when
subjected to heat shock. To determine whether PKH1 and
PKH2 have a common function, the AC301 strain was
crossed with the AC303 strain. Upon sporulation of the
resulting doubly heterozygous diploid (AC306), the major-
ity of the 30 tetrads dissected yielded three viable spores
and one non-viable spore. The viable spores were
analysed both by plating on appropriate selective media
and by PCR. None of the viable haploid cells were Trp+
and His+, and none carried both the pkh1∆ and the pkh2∆
mutations. Microscopic observation of the non-viable
spores revealed that most germinated and underwent
2–3 cycles of cell division before ceasing to grow. Hence,
pkh1∆ pkh2∆ double mutants are inviable, indicating that
PKH1 and PKH2 encode genes that are functionally
redundant and share some role that is essential for cell
growth and survival.
To confirm that the lethality of pkh1∆ pkh2∆ cells is due
solely to the absence of PKH1 or PKH2 function, the
doubly heterozygous diploid strain AC306 was trans-
formed with either YEplac195-PKH1, a URA3-marked
plasmid expressing PKH1 from its own promoter, or the
empty vector (YEplac195), and the resulting Ura+ trans-
formants were subjected to sporulation and tetrad dissec-
tion. Many Trp+His+ and Ura+ spore clones were
obtained from the diploid strain transformed with
YEp195-PKH1, but not from that transformed with
empty vector (data not shown). Thus, the pkh1∆ pkh2∆
double mutant was able to survive if PKH1 expression
was restored. Likewise, when AC306 was transformed
with a URA3-marked plasmid (pYES2) expressing either
PKH1 (Figure 2a) or PKH2 (data not shown) from the
GAL1 promoter, it was possible to obtain viable pkh1∆
pkh2∆ spores, even when the cells were propagated on
glucose (presumably because these constructs are not
efficiently repressed on this carbon source [30]). Most
significantly, when the pkh1∆ pkh2∆ cells harbouring
Research Paper  S. cerevisiae PDK1 and SGK homologues Casamayor et al. 187
pYES2-PKH1 (Figure 2a) or pYES2-PKH2 (data not
shown) were plated on medium containing 5-fluoro-
orotic acid (5-FOA), which selects for cells that lack a
functional URA3 gene [31] and, hence, for loss of the
URA3-marked plasmid, the pkh1∆ pkh2∆ cells were no
longer capable of growing (Figure 2a). 
Human PDK1 is a functional homologue of Pkh1 and Pkh2 
To determine whether Pkh1 and Pkh2 are similar to
PDK1 in function, as well as in sequence, the AC306
strain was transformed with YEplac195 plasmids contain-
ing genes encoding either full-length human PDK1 or
human PDK1 lacking the carboxy-terminal PH domain
188 Current Biology, Vol 9 No 4
Figure 1
Comparison of the primary structures of Pkh1
and Pkh2 with PDK1. (a) Alignment of the
deduced amino-acid sequences of yeast Pkh1
and Pkh2 with the catalytic domains of human
PDK1 and its Drosophila homologue,
DSTPK61 [27], carried out using the
CLUSTAL W program. Identical residues are
denoted by white letters on a black
background, and similar residues by white
letters on a grey background. Dashes
represent gaps introduced in the sequences
to optimise the alignment. Five independent
PKH1 clones that we generated by PCR all
differed from the sequence deposited in the
Saccharomyces Genome Database,
indicating that Phe187 (nucleotide sequence
TTC) should actually be an isoleucine residue
(ATC). (b) Schematic diagrams of the
structures of the PDK1-related proteins. Dark
grey boxes indicate the catalytic domain in
each protein kinase and light grey boxes
indicate PH domains. 
(a)
PDK1      84 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAK  163
DSTPK61  164 FGRYIGEGSYSIVYLAVDIHSRREYAIKVCEKRLILRERKQDYIKREREVMHQMTNVPGFVNLSCTFQDQRSLYFVMTYAR  244
Pkh1     127 FGEQLGDGSYSSVVLATARDSGKKYAVKVLSKEYLIRQKKVKYVTVEKLALQKLNGTKGIFKLFFTFQDEASLYFLLEYAP  207
Pkh2     181 FGSVIGDGAYSTVMLATSIDTKKRYAAKVLNKEYLIRQKKVKYVSIEKTALQKLNNSPSVVRLFSTFQDESSLYFLLEYAP  261
PDK1     164 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS-------------  231
DSTPK61  245 KGDMLPYINRVGSFDVACTRHYAAELLLACEHMHRRNVVHRDLKPENILLDEDMHTLIADFGSAKVMTAHERALATEHCSE  325
Pkh1     208 HGDFLGLIKKYGSLNETCARYYASQIIDAVDSLHNIGIIHRDIKPENILLDKNMKVKLTDFGTAKILPE------------  276
Pkh2     262 NGDFLSLMKKYGSLDETCARYYAAQIIDAIDYLHSNGIIHRDIKPENILLDGEMKIKLTDFGTAKLLN-------------  329
PDK1     232 ---------------------------------------------PESKQ-----ARANSFVGTAQYVSPELLTEKSACKS  262
DSTPK61  326 QRRSNSDEDDEDSDRLENEDEDFYDRDSEELDDRDDEQQQEEMDSPRHRQRRYNRHRKASFVGTAQYVSPEVLQNGPITPA  406
Pkh1     277 ----------------------------------------EPSNTADGKPYFDLYAKSKSFVGTAEYVSPELLNDNYTDSR  317
Pkh2     330 -----------------------------------------PTNNSVSKPEYDLSTRSKSFVGTAEYVSPELLNDSFTDYR  369
PDK1     263 SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP-LKAHPF   341
DSTPK61  407 ADLWALGCIVYQMIAGLPPFRGSNDYVIFKEILDCAVDFPQGFDKDAEDLVRKLLRVDPRDRLGAQDEFGYYESIRAHPF   486
Pkh1     318 CDIWAFGCILYQMLAGKPPFKAANEYLTFQKVMKIQYAFTAGFPQIVKDLVKKLLVRDPNDRL-------TIKQIKAHLF   390
Pkh2     370 CDIWAFGCILFQMIAGKPPFKATNEYLTFQKVMKVQYAFTPGFPLIIRDLVKKILVKNLDRRL-------TISQIKEHHF   442
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Figure 2
Loss of both PKH1 and PKH2 causes
inviability and either intact human PDK1 or
PDK1-∆PH can restore viability to pkh1∆
pkh2∆ cells. (a) Four spores (wild type (wt);
pkh1∆; pkh2∆; and pkh1∆ pkh2∆) derived
from a tetratype ascus of diploid strain AC306
that had been transformed with plasmid
pYES2-PKH1 (which is marked with URA3)
were plated either on medium lacking uracil
(SD-Ura) to select for the presence of the
plasmid, or on medium containing 5-FOA to
select for loss of the plasmid [31]. (b) Four
spores, as in (a), derived from a tetratype
ascus of strain AC306 that was transformed
with either YEplac195-PDK1 or YEplac195-
PDK1-∆PH (which are marked with URA3), as
indicated, were plated either on medium
lacking uracil (SD-Ura) to select for the
presence of the plasmids (only one
representative plate is shown), or on medium
containing 5-FOA to select for loss of 
the plasmids. 
YEplac195-PDK1
SD-Ura
5-FOA 5-FOA
5-FOA
pYES2-PKH1 pYES2-PKH1
wt
pkh1∆ pkh2∆
pkh1∆
pkh2∆
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YEplac195-PDK1-∆PH1
YEplac195-PDK-∆PH
wt
pkh1∆ pkh2∆
pkh1∆
pkh2∆ 
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(PDK1-∆PH) under control of the authentic PKH1 pro-
moter. Expression of either PDK1 or PDK1-∆PH from
this vector permitted the recovery of viable pkh1∆ pkh2∆
spores. Moreover, selection against these URA3-marked
plasmids by plating on 5-FOA-containing medium pre-
vented the growth of the pkh1∆ pkh2∆ double mutants,
but not a pkh1∆ or a pkh2∆ single mutant carrying the same
plasmids (Figure 2b). Viable pkh∆ pkh2∆ double mutant
spores could also be recovered when AC306 was trans-
formed with pYES2 plasmids containing genes encoding
either PDK1 or PDK1-∆PH driven by the GAL1 promoter,
even when the cells were germinated and grown on
glucose-containing medium (data not shown). These
results demonstrate that the catalytic domain of human
PDK1 is able to phosphorylate the same essential sub-
strates in yeast cells as Pkh1 and Pkh2.
Purification and characterisation of Pkh1 kinase activity 
Pkh1 was expressed as a glutathione-S-transferase (GST)
fusion protein in human 293 cells and purified from cell
lysates by affinity chromatography on glutathione–Sepharose.
This process yielded a single protein that migrated with
the expected molecular mass (112 kDa) by SDS–PAGE. A
catalytically inactive (kinase-dead) mutant, which contains
a substitution of the conserved residue (alanine for aspartic
acid) critical for binding to the Mg2+–ATP substrate,
Pkh1(D267A), was also expressed and purified, and served
as a control. GST–Pkh1 activity was measured via its
ability to phosphorylate and activate GST–PKBα, a known
substrate of human PDK1. The phosphorylation of PKBα
was assessed by the incorporation of label in reactions 
containing [γ-32P]ATP. The activity of PKBα was followed
via its ability, after incubation with GST–Pkh1, to phos-
phorylate a specific peptide substrate (crosstide) [32].
Yeast Pkh1 was able to activate human PKBα (Figure 3a),
provided that lipid vesicles containing PI(3,4,5)P3 or
PI(3,4)P2 were present. The Pkh1-dependent phosphory-
lation of PKBα correlated well with the degree of activa-
tion observed. No activation or phosphorylation of PKBα
was observed if PI(3,4,5)P3 or PI(3,4)P2 were omitted, or if
these lipids were replaced by PI(4,5)P2 or PI(3)P
(Figure 3a). As observed with human PDK1 (Figure 3b),
Pkh1 phosphorylated and activated PKBα more efficiently
in the presence of the naturally occurring stearoyl–arachi-
donyl derivative of PI(3,4,5)P3 than in the presence of the
dipalmitoyl derivative. GST–Pkh1(D267A) did not acti-
vate or phosphorylate PKBα under any condition tested
(data not shown). 
To determine the residue phosphorylated by Pkh1,
GST–PKBα was phosphorylated to completion by pro-
longed incubation in the presence of [γ-32P]ATP, cleaved
with trypsin, and the resulting digest resolved by high per-
formance liquid chromatography (HPLC) on an RP-C18
column. Only one major phosphopeptide was obtained
(data not shown). Elution of this species was congruent
with that of the phosphopeptide (residues 308–328)
obtained by tryptic digestion of PDK1-phosphorylated
PKBα. No 32P-labelled material eluted at the position cor-
responding to the PKBα peptide that contains Ser473.
The peptide labelled by Pkh1 contained phosphothreo-
nine (and no other phosphoamino acid) and all of the
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Phosphorylation and activation of human PKBα by yeast Pkh1 and
human PDK1, and phosphorylation and activation of yeast Ypk1 and
human SGK by yeast Pkh1. (a,b) Purified GST–PKBα was incubated
for 30 min at 30°C with either (a) GST–Pkh1 or (b) GST–PDK1 in the
presence of 100 µM ATP and phospholipid vesicles containing
100 µM phosphatidylcholine and 100 µM phosphatidylserine together
with the various PI lipids indicated (where SA denotes
stearoyl–arachidonyl derivatives and DP denotes dipalmitoyl
derivatives), all at a final concentration of 10 µM. The phosphorylation
of GST–PKBα and the increase in its specific activity (relative to
control incubations in which GST–Pkh1 or GST–PDK1 were omitted)
were determined (see Materials and methods). (c,d) Either
(c) GST–Ypk1 or (d) GST-SGK were incubated for 30 min at 30°C
with GST–Pkh1, as indicated, in the presence of 100 µM ATP, with or
without phospholipid vesicles containing 100 µM phosphatidylcholine,
100 µM phosphatidylserine and 10 µM of SA-PI(3,4,5)P3, collectively
termed PI(3,4,5)P3. Reactions were terminated and the degree of
activation and phosphorylation was determined.
radioactivity was released after one cycle of Edman degra-
dation (data not shown). This analysis establishes that
yeast Pkh1 phosphorylates PKBα at Thr308. 
YPK1 and YKR2 encode homologues of mammalian SGK 
PKBα is one founding member of the so-called AGC sub-
family of protein kinases, several of which possess the con-
served PDK1 phosphorylation site in their activation loop
and a distal PDK2 phosphorylation site (Figure 4a). There
are four previously characterised protein kinases in S. cere-
visiae that possess both motifs (Figure 4a), suggesting that
one or more might be physiological substrates for Pkh1
and/or Pkh2. These four protein kinases are the products
of the YPK1 [33], YKR2/YPK2 [34,35], SCH9 [36], and
PKC1 [37] genes. Ypk1 and Ykr2 are 88% identical in their
catalytic domains and have extensive similarities across
their amino-terminal and carboxy-terminal extensions
(Figure 4b). Among mammalian protein kinases, the cat-
alytic domains of Ypk1 and Ykr2 share greatest similarity
to SGK (55% identity), PKB/c-Akt (52% identity), p70 S6
kinase (50% identity) and βARK (38% identity;
Figure 4b). Although βARK is considered to be an AGC
family member [38], it lacks the PDK1 and PDK2 motifs. 
YPK1 and YKR2 are essential genes that are functionally
redundant 
Cells lacking either Ypk1 or Ykr2 are viable, whereas cells
lacking both Ypk1 and Ykr2 are inviable [35]. We estab-
lished conditions for testing the ability of potential mam-
malian homologues to rescue this inviability. For this
purpose, otherwise isogenic ypk1∆::HIS3 and ykr2∆::TRP1
haploid strains (YES5 and YES1, respectively) were
crossed and the resulting diploid strain (YES7) was trans-
formed with a LEU2-marked plasmid expressing the
YKR2 gene under the tight control of the GAL1 promoter.
When subjected to sporulation and tetrad dissection on
galactose-containing medium, most of the tetrads yielded
four viable spores, and His+Trp+Leu+ isolates were readily
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Figure 4
Consensus sites for PDK1-dependent and
PDK2-dependent phosphorylation, and
comparison of the primary structures of Ypk1
and Ykr2 with their closest mammalian
homologues. (a) Conserved motifs predicted
to be phosphorylated by PDK1-like and
PDK2-like enzymes are indicated with the
residue phosphorylated shown in bold type. In
all cases, the putative PDK2 phosphorylation
site is located 157–166 residues carboxy-
terminal to the PDK1 phosphorylation site.
GenBank accession numbers: PKBα,
X65687; SGK, Y10032; p70 S6Kα,
M60725; PKCζ, L07032; Ypk1, P12688;
Ykr2, P18961; Pkc1, M32491; and Sch9,
U00029. (b) Alignment of Ypk1 and Ykr2 to
each other and to mammalian SGK, PKBα,
p70 S6 kinase (S6K) and βARK: those
residues in Ypk1 that are conserved in at least
one of the other kinases are indicated by
black letters on a grey background. 
(a)
Human enzymes
PKBα 303  GATMKTFCGTPEYLAPE.........FPQFSYSAS   477
SGK 251  NSTTSTFCGTPEYLAPE.........FLGFSYAPP   426
p70 S6Kα 224  GTVTHTFCGTIEYMAPE.........FLGFTYVAP   393
PKCζ 533  DAKTNTFCGTPDYIAPE.........FRNFSFMNP   699
Yeast enzymes
Ypk1 499  DDKTDTFCGTPEYLAPE.........FGGWTYVGN   666
Ykr2 496  NDKTDTFCGTPEYLAPE.........FGGWTYIGD   663
Pkc1 978  GNRTSTFCGTPEFMAPE.........FRGFSFMPD  1147
Sch9 565  KDRTNTFCGTTEYLAPE.........FAGFTFVDE   741
PDK1
phosphorylation site
PDK2
phosphorylation site
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IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIGMEDTACFYLAEISMALGHLHQKG-IIYRDLKPENIMLN
IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAADIILGLEHMHNRF-VVYRDLKPANILLD
YQGHIALCDFGLCKLNMKDDDKTDTFCGTPEYLAPELLLG-LGYTKAVDWWTLGVLLYEMLTGLPPYYDEDVPK
YQGHIALCDFGLCKLNMKDNDKTDTFCGTPEYLAPEILLG-QGYTKTVDWWTLGILLYEMMTGLPPYYDENVPV
SQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE
KDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK
HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK
EHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCNLFKLLRGHSPFRQHKTKD
IYKKILQEP---LVFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAD--EIRNHPFFSQLSWKRLLMKGYIPPYKP
MYKKILQQP---LLFPDGFDPAAKDLLIGLLSRDPSRRLGVNGTD--EIRNHPFFKDISWKKLLLKGYIPPYKP
MYDNILNKP---LQLKPNITNSARHLLEGLLQKDRTKRLGAK-DDFMEIKSHIFFSLINWDDLINKKITPPFNP
LFELILMEE---IRFPRTLGPEAKSLLSGLLKKDPTQRLGGGSEDAKEIMQHRFFANIVWQDVYEKKLSPPFKP
TIDKILKCK---LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKP
KHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIP
AVSNSMDTSNFD-EEFTREKP-IDSVVD---EYLSESVQKQ----FGGWTYVGNEQLGSSMVQGRSIR.
IVKSEIDTANFD-QEFTKEKP-IDSVVD---EYLSASIQKQ----FGGWTYIGDEQLGDSPSQGRSIS.
NVSGPSDLRHFD-PEFTEEPV-PSSIGRSPDSILVTASVKEAAEAFLGFSYAPPMDSFL.
QVTSETDTRYFD-EEFTAQMI-TITPPD--QDDSMECVDSERRPHFPQFSYSASGTA.
LLQSEEDVSQFD-SKFTRQTP-VDSPDD---STLSESANQV----FLGFTYVAPSVLESVKEKFSFEP
PRGEVNAADLFDIGSFDEEDTKGIKLLDSDQELYRNFPLTI-SERWQQEVAETVFDTINAETDRLEAR
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recovered. The ypk1∆ ykr2∆ double mutants carrying
pGAL-YKR2 could be maintained on galactose medium,
but failed to grow when streaked onto glucose medium,
whereas otherwise isogenic wild-type cells or ypk1∆ and
ykr2∆ single mutants carrying the same plasmid grew well
on glucose (Figure 5). These results confirm that Ypk1
and Ykr2 share some role that is essential for cell growth
and survival. 
SGK is a functional homologue of Ypk1 and Ykr2
To construct a strain for conveniently testing complemen-
tation of the ypk1∆ ykr2∆ double mutant by mammalian
protein kinases, the diploid YES7 strain was transformed
with a URA3-marked low-copy-number (CEN) plasmid
expressing YKR2 from its own promoter, and a haploid
ypk1∆ ykr2∆ double mutant strain maintained by expres-
sion of YKR2 from the plasmid (strain YPT28) was recov-
ered. The YPT28 strain was then transformed with either
empty LEU2-marked, high-copy-number (2 µm DNA)
vectors (pAD4M or YEp351GAL) or the same vectors
expressing (from either the GAL1 promoter or the constitu-
tive ADH1 promoter [39]) YPK1, YKR2, or cDNAs encod-
ing rat SGK, mouse PKB/c-AKT, rat p70 S6 kinase, or
bovine βARK. All of these strains are able to grow on
galactose medium due to the presence of the plasmid
expressing YKR2, which also demonstrated that expression
of none of the heterologous protein kinases tested was
deleterious to yeast cell growth (Figure 6a). In contrast,
when plated on the same medium containing 5-FOA,
thereby demanding loss of the pYKR2(URA3) plasmid,
ypk1∆ ykr2∆ cells carrying the empty vectors were unable
to grow, whereas those harbouring plasmids expressing
either YPK1 or YKR2 remained viable, as expected. 
Of the four mammalian cDNAs tested, only SGK dis-
played efficient complementation by permitting growth
on 5-FOA (Figure 6a). Weak complementation by PKB
was reproducibly observed, in that a small percentage of
the colonies were able to survive (possibly cells expressing
exceedingly high levels of PKB due to elevated copy
number of the 2 µm DNA plasmid resulting from its poor
segregation efficiency [40]). Each mammalian protein
kinase was produced at a readily detectable level in yeast
(grown on SCGal-Leu), as judged by immunoblotting
with appropriate antibodies, and was active, as judged by
assaying extracts of the yeast cells with appropriate spe-
cific substrates (data not shown); hence, the failure of p70
S6 kinase and βARK to complement was not due to their
lack of expression. Because p70 S6 kinase is under such
complex regulation in animal cells [41,42], various amino-
terminal and carboxy-terminal truncations [43] were also
tested in the same way; although all were expressed, none
were able to complement (data not shown). To confirm
these results by an independent method, the same plas-
mids were introduced into a yeast strain (YPT40) that dis-
plays temperature-conditional growth because it carries a
null mutation in YKR2 (ykr2∆) and a temperature-sensi-
tive (ts) mutation in YPK1 (ypk1-1ts). All of the transfor-
mants were able to grow at the permissive temperature
(26°C). However, the strain carrying an empty vector
(YEp351GAL) was unable to survive at the restrictive
temperature (35°C), although the strain expressing YPK1
from the same vector grew well (Figure 6b). As observed
before, the same cells expressing SGK were able to grow
well at 35°C. Cells expressing PKB were able to grow
weakly, in that microcolonies were observed outside of the
heavy initial streak. In contrast, cells expressing p70 S6
kinase or βARK did not grow (Figure 6b). 
Ypk1 and mammalian SGK are efficient substrates for Pkh1
On the basis of the above observations, Ypk1 (and/or
Ykr2) should be physiological substrates of Pkh1 (and/or
Pkh2). Likewise, as PDK1 is able to phosphorylate and
activate SGK [23], yeast Pkh1 (and/or Pkh2) should be
able to phosphorylate and activate mammalian SGK. To
test these predictions, Ypk1 and SGK (lacking its amino-
terminal 60 amino acids) were expressed as GST fusion
proteins in 293 cells and purified. Each purified protein
yielded a single band following SDS–PAGE that had the
expected molecular mass (data not shown). In the absence
of any other factor, purified GST–Ypk1 displayed no
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Figure 5
Expression of either Ypk1 or Ykr2 is required for viability. Strain YES7,
transformed with the LEU2-marked plasmid, pGAL-YKR2, was
sporulated on medium lacking leucine and containing galactose to
select for the presence of the plasmid and to induce expression of
YKR2 from the plasmid. The four spores of a tetratype ascus (wild type
(wt); ypk1∆; ykr2∆; ypk1∆ ykr2∆) derived from this diploid were
recovered on this medium (SCGal-Leu) and then subsequently streaked
on the same medium containing glucose as the carbon source (SCGlc-
Leu) to repress expression of the plasmid-borne YKR2 gene.
SCGal-Leu SCGlc-Leu
pGAL-YKR2 pGAL-YKR2
ypk1∆ wt
ykr2∆ ypk1∆
ykr2∆
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detectable activity towards the crosstide peptide sub-
strate; however, after pre-incubation with purified
GST–Pkh1, GST–Ypk1 was activated and catalysed a
readily detectable level of incorporation into the substrate,
in the presence or absence of lipid vesicles containing
PI(3,4,5)P3 (Figure 3c). Consistent with activation result-
ing from Pkh1-dependent phosphorylation, incorporation
of label into GST–Ypk1 was readily detected when
[γ-32P]ATP was included in the reaction and was present
exclusively as phosphothreonine (data not shown). A
kinase-dead derivative, GST–Ypk1(D488A), was phos-
phorylated by GST–Pkh1 but, as expected, was not cat-
alytically active (data not shown). Also, as predicted,
GST–SGK was both phosphorylated and activated upon
incubation in vitro with GST–Pkh1 (Figure 3d). More-
over, the site phosphorylated in SGK by Pkh1 was
mapped to Thr256 (data not shown), the same site as that
phosphorylated by PDK1 [23].
As one means to map the Pkh1 phosphorylation site in
Ypk1, a GST–Ypk1(T504D) mutant, which contains a thre-
onine to aspartic acid substitution at position 504 in the pre-
sumptive PDK1-like site (Figure 4a), was expressed in 293
cells and purified. GST–Ypk1(T504D) was not detectably
phosphorylated by Pkh1 (Figure 7), consistent with the
conclusion that Pkh1 phosphorylates Ypk1 at this residue.
As GST–Ypk1(T504D) was neither constitutively active
nor activated by Pkh1, the aspartic acid residue at this posi-
tion cannot substitute for phosphothreonine in the activa-
tion of this protein kinase. A similar result has been
obtained for SGK [23]. Ypk1 also contains a putative con-
sensus site (Thr662) for PDK2 phosphorylation (Figure 4a).
A GST–Ypk1 fusion protein containing a threonine to
aspartic acid mutation of this site, GST–Ypk1(T662D), was
expressed and purified from 293 cells and was also inactive;
however, this protein was phosphorylated and activated by
Pkh1 in a manner identical to GST–Ypk1 itself (Figure 7).
When both Thr504 and Thr662 were mutated to aspartic
acid residues, creating GST–Ypk1(T504D T662D), this
mutant also displayed no detectable activity (before or after
incubation with Mg2+–ATP and GST–Pkh1), demonstrat-
ing that, unlike PKBα, mutation of these residues to aspar-
tic acid residues cannot substitute for phosphothreonine to
produce a constitutively active enzyme. A similar observa-
tion has been made for SGK [23].
Pkh1 acts on Ypk1 in vivo
A functional Ypk1 derivative tagged at its carboxyl terminus
with a c-Myc epitope was expressed in cells that were meta-
bolically labelled with [32P]PO43–; the Ypk1 derivative was
then immunoprecipitated with the anti-Myc antibody 9E10.
When compared with the level of incorporation observed in
control (PKH1+ PKH2+) cells, labelling of Ypk1 was repro-
ducibly reduced (by 53 ± 20%) in pkh1∆ mutants, but not
affected (within 10 ± 5% of control) in pkh2∆ mutants (see
Supplementary material published with this paper on the
internet). These results suggest that Pkh1 contributes to
phosphorylation of Ypk1 in vivo and are consistent with the
above findings in vitro. In agreement with these conclu-
sions, overproduction of Pkh1 rescued the inviability of the
ypk1-1ts ykr2∆ strain at the non-permissive temperature,
whereas Pkh2 overexpression did not (Figure 8). Moreover,
as would be expected if this suppression arises from a direct
physical interaction between Pkh1 and the mutant Ypk1
protein that persists at the restrictive temperature
(Figure 8a), neither overproduced Pkh1 (Figure 8b) nor
overproduced Pkh2 (data not shown) was able to rescue a
ypk1∆ ykr2∆ strain, which lacks Ypk1 protein (Figure 8c).
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Figure 6
SGK rescues the inviability of ypk1∆ ykr2∆
cells. (a) Strain YPT28 carrying pYKR2, a
URA3-marked plasmid that expresses YKR2
from its authentic promoter, was generated and
transformed with either empty LEU2-marked
vectors pAD4M (pADH) or YEp351GAL
(pGAL) or the same vectors expressing from
either the ADH1 or the GAL1 promoters, as
indicated, either YPK1, YKR2, SGK, PKBα,
p70 S6 kinase (S6K) or βARK. The resulting
transformants were then streaked onto medium
selective for the presence of both plasmids
(SCGal-Leu) or onto the same medium
containing 5-FOA, thereby demanding loss of
the URA3-marked plasmid expressing YKR2.
(b) Strain YPT40 (ypk1-1ts ykr2∆) was
constructed, transformed with the indicated
plasmids described in (a), then streaked on
selective medium and incubated at either a
permissive temperature (26°C) or a restrictive
temperature (35°C).
26˚C 35˚C
pYKR2(URA3) pYKR2(URA3) ypk1-1ts ykr2∆ ypk1-1ts ykr2∆
SCGal-Leu + 5-FOA(a) (b)
pGAL
pADH
pADH-
SGK
pGAL-
S6K
pGAL-
S6K
pGAL-
YPK1
pGAL-
PKBα
pGAL
pADH-
YPK1
pADH-
SGK
pGAL-
YKR2 pGAL-
PKBα
pADH-
βARK
pADH-
βARK
Current Biology
Substrate specificities of Ypk1, SGK and PKB are similar
PKBα phosphorylates substrates at the minimal consensus
sequence Arg–X–Arg–X–X–Ser–Hyd, (where the bold Ser
represents the phosphorylated amino acid and Hyd repre-
sents a bulky hydrophobic residue) [44]. Likewise, SGK
requires arginine at the –5 and –3 positions (numbering
with respect to Ser) for efficient phosphorylation, although
the requirement for a large hydrophobic residue at +1 is
less stringent [23]. Using peptide substrates, the substrate
selectivity of Pkh1-activated Ypk1 was quite similar to
that of PDK1-activated PKBα and PDK1-activated SGK
(Table 1). For example, mutation of either of the arginine
residues, even to lysine residues, drastically reduced phos-
phorylation by Ypk1.
Discussion
We have shown that S. cerevisiae contains protein kinases
that are similar to mammalian PDK1 and SGK, in terms of
sequence, physiological function in vivo, and biochemical
specificity in vitro. We demonstrated that the PKH1 and
PKH2 genes encode PDK1-like protein kinases. The
function(s) of Pkh1 and Pkh2 must overlap because loss of
either enzyme causes no obvious phenotype, whereas the
deficiency of both proteins results in inviability. The cat-
alytic domain of mammalian PDK1 alone was sufficient to
rescue cells from this lethality. Consistent with this
finding, purified Pkh1 phosphorylates and activates
known substrates of mammalian PDK1, including PKBα
and SGK, and phosphorylates the same residue in these
substrates as that phosphorylated by PDK1 (Thr308 in
PKBα and Thr256 in SGK).
Next, we demonstrated that the YPK1 and YKR2 gene
products are SGK-like protein kinases. Although loss of
Ykr2 produces no discernable phenotype, absence of Ypk1
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Figure 7
Phosphorylation of Thr504 in Ypk1 is essential for its activation by
Pkh1. (a) GST–Ypk1, GST–Ypk1(T504D), GST–Ypk1(T662D) or
GST–Ypk1(T504D T662D) were incubated with either GST–Pkh1 or
a catalytically inactive derivative, GST–Pkh1(D267A), as indicated, for
30 min at 30°C with ATP (100 µM). Reactions were terminated and
the degree of activation assessed as indicated in the legend to
Figure 3. (b) The reactions in (a) were carried out in the presence of
100 µM [γ-32P]ATP and the products were analysed by SDS–PAGE
followed by autoradiography to follow the amount of phosphate
incorporation into GST–Ypk1 and its various derivatives, as described
in the legend to Figure 3.
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Figure 8
Overexpression of Pkh1 suppresses a temperature-sensitive Ypk1
mutant. (a) As judged by immunoblotting with rabbit polyclonal anti-Ypk1
antibodies, a polypeptide of the size predicted for Ypk1 was present in
wild-type cells (wt), absent in a ypk1∆ mutant, overproduced in a cell
expressing YPK1 from a constitutive promoter (ADH1) on a multi-copy
plasmid (pAD4M), as indicated, and persisted when strain YPT40 
(ypk1-1ts ykr2∆) was grown in rich medium at 30°C and then shifted to
the restrictive temperature (37°C) for 3 h. (b) A wild-type strain (W303-
1A) carrying a plasmid (pGAL-PKH1-HA), that expresses from the GAL1
promoter a version of Pkh1 tagged with an epitope derived from influenza
virus haemagglutinin (HA), was grown in raffinose medium (R), and then a
portion shifted to galactose medium (Gal) for 2 h, prior to analysis by
SDS–PAGE and immunoblotting with a mouse anti-HA monoclonal
antibody. (c) Strains YPT40 (ypk1-1ts ykr2∆) or YPT28 (ypk1∆ ykr2∆
pYKR2(URA3)) were transformed with the indicated LEU2-marked
plasmids. The YPT40 derivatives were streaked on selective medium
(SCGal-Leu) and incubated at the indicated temperatures for 3 days. The
YPT28 derivatives were streaked on the same medium in the presence or
absence of 5-FOA and incubated for 3 days at 30°C.
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pADH-YPK1 – –– –+
ypk1∆ wt wt ypk1-1tsykr2∆
30 37Temperature (˚C) 303030
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Ypk1
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causes slower cell growth and removal of both Ykr2 and
Ypk1 causes inviability [35,45], indicating that these
enzymes have some functional redundancy. Expression of
SGK, a close relative of PKBα that lacks an obvious
amino-terminal PH domain, rescued this inviability effi-
ciently. PKB itself was able to sustain the growth of the
ypk1∆ ykr2∆ cells only very weakly. Indeed, PKB in yeast
should exist in an inactive state because S. cerevisiae lacks
the enzymatic machinery necessary to generate PI(3,4,5)P3
or PI(3,4)P2 [46–48]. This situation could explain why
Pkh1, Pkh2, Ypk1 and Ykr2 lack discernible PH domains
and why Pkh1-dependent activation of Ypk1 in vitro is not
affected by the presence or absence of these 3-phospho-
inositides. In fact, Pkh1 does not bind PI(3,4,5)P3 under
conditions where this phospholipid binds tightly to PDK1
and PKBα (R. Currie and C.P. Downes, personal commu-
nication). Therefore, our finding that Pkh1-mediated acti-
vation of PKBα only occurred in the presence of lipid
vesicles containing PI(3,4,5)P3 or PI(3,4)P2 confirms that
these 3-phosphoinositides exert their effect by interacting
with the PH domain of PKBα and thereby enhancing the
accessibility of its PDK1 site. Signals that activate Pkh1
and Pkh2 or recruit these enzymes to particular subcellular
locations are not yet known. Likewise, signals that
promote or prevent encounter of Ypk1 and Ykr2 with Pkh1
and Pkh2 are also unknown.
Other protein kinases highly related to Ypk1 and Ykr2
(including p70 S6 kinase and βARK) did not support
growth of cells deficient in both Ypk1 and Ykr2, even
though these kinases were expressed in an active form in
yeast. Thus, functional complementation strongly argues
that SGK is the most similar kinase to Ypk1 and Ykr2.
Consistent with this view, both SGK and PKBα served as
substrates for and were activated by yeast Pkh1. Con-
versely, Ypk1 was a good substrate for and was activated
by PDK1. Moreover, Pkh1-activated Ypk1 had a similar
substrate specificity in vitro to that of PDK1-activated
PKBα and SGK, at least on peptide substrates. Further-
more, we showed that Pkh1 is able to phosphorylate and
activate Ypk1 in vitro, is required for optimal phosphoryla-
tion of Ypk1 in vivo, and, when overproduced, is able to
stabilise a temperature-sensitive Ypk1 mutant. Mutagene-
sis studies indicated that Pkh1 phosphorylates Ypk1 at
Thr504, which resides in a context equivalent to Thr308
in PKBα and Thr256 in SGK, the sites phosphorylated by
PDK1 (and Pkh1). Collectively, these results indicate that
Ypk1 (and, most likely, Ykr2) lie downstream of Pkh1
(and/or Pkh2) in a protein kinase cascade that is essential
for both the growth and survival of yeast cells. 
PDK1 seems to be responsible for the activation of a
number of different classes of signal-transducing protein
kinases. Likewise, in yeast, evidence suggests that Pkh1
and Pkh2 may have other targets in addition to Ypk1 and
Ykr2. First, human PKBα can be partially activated by a
T308D mutation (in the PDK1 site) or by a S473D muta-
tion (in the PDK2 site), and almost fully activated by both
mutations [24]; nonetheless, expression of PKBα(T308D
S473D), with or without its PH domain, is unable to
support sustained vegetative growth of either pkh1∆ pkh2∆
or ypk1∆ ykr2∆ cells (A.C, and P.D.T., unpublished obser-
vations). Second, high levels of overexpression (~50-fold)
of either Ypk1 or Ykr2 from the GAL1 promoter on a
multi-copy plasmid does not bypass the need for Pkh1 and
Pkh2 function (P.D.T., unpublished observations), sug-
gesting that Pkh1 and/or Pkh2 have other substrates
essential for cell viability or that Ypk1 and Ykr2 possess no
basal activity at all in the absence of Pkh1- and/or Pkh2-
dependent phosphorylation. As we have described here,
mutation of Thr504 or Thr662 (or both) to aspartic acid
residues does not generate constitutively active Ypk1;
likewise, SGK(T256D S422D), which contains the equiv-
alent mutations, is also not constitutively active [23].
Hence, we do not know if constitutive activation of Ypk1
(or SGK) would be sufficient to rescue the lethality of a
pkh1∆ pkh2∆ double mutant. A third reason to suspect that
Pkh1 and Pkh2 have multiple essential targets is that a
potential substrate, Pkc1, is necessary for yeast cell viabil-
ity under standard growth conditions [37]; yet, overexpres-
sion of PKC1 does not rescue the lethality of pkh1∆ pkh2∆
cells (A.C., unpublished observations). Likewise, absence
of another potential Pkh1 and Pkh2 target, Sch9, which
serves as an effector enzyme in a pathway parallel to (and
largely redundant in function with) the three yeast PKA
catalytic subunits (Tpk1, Tpk2 and Tpk3) [36,49], is suffi-
cient to cause very slow growth. Tpk1, Tpk2 and Tpk3,
Table 1
Substrate selectivity of yeast Ypk1 and mammalian PKBα.
Peptide Relative rate of phosphorylation (at 30 µM)
GST–Ypk1 GST–PKBα GST–SGK†
1 GRPRTSSFAEG (100) (100) 100
2 RPRTSSF 92 139 154
3 KPRTSSF 11 6 2
4 RPKTSSF 5 30 49
5 RPRTSAF 0 0* 0
6 PRTSSF 0 0* 0
7 RPRTSS 0 2* 10
8 KKRNRTLSVA 133 157 ND
9 KKKNRTLSVA 28 13 ND
10 KKRNKTLSVA 14 25 ND
11 RPRTSSF 92 139 154
12 RPRTSSV 24 67 131
13 RPRTSSL 31 69 135
14 RPRTSSA 9 26 107
15 RPRTSSK 14 67* 146
16 RPRTSSE 6 21 84
*Data taken from [44]. †Data taken from [23]. ND, not determined. Bold
residues indicate the phosphorylated site, and the underlined residues
those that have been altered. 
which comprise an essential gene set [36], may themselves
be substrates for Pkh1 and/or Pkh2 as all three possess a
PDK1-like phosphorylation site [22].
Like mammalian PDK1 targets, Ypk1 and other suspected
substrates for yeast Pkh1 and Pkh2 (except Tpk1, Tpk2
and Tpk3) contain the consensus PDK2 sequence
(Phe–X–X–Ar–Ser/Thr–Ar, where the bold residue is the
phosphorylated amino acid and Ar represents an aromatic
residue) located at about the same position (160–165
residues carboxy-terminal) relative to the threonine
residue phosphorylated by Pkh1. This conservation
strongly suggests that S. cerevisiae possesses a PDK2-like
activity that may act coordinately with Pkh1 and Pkh2 to
modulate the state of activation of a number of target
protein kinases, as observed for PDK1 and PDK2 in
animal cells.
Since the submission of this manuscript, the identification
of the Schizosaccharomyces pombe gene ksg1 has been pub-
lished. The ksg gene has structural homology with
PKH1/PKH2 and is also essential for growth, but is not
essential for spore germination [50].
Materials and methods
Gene disruptions and strain constructions
A PCR-based method [51] was used for disruption of the PKH1 and
PKH2 genes. The HIS3 marker was obtained from pRS313, and the
TRP1 marker from pRS314 [52]. The ypk1-∆1::HIS3 allele and the
ykr2-∆1::TRP1 alleles [45] will be described in greater detail else-
where (P.D.T., E.A. Schnieders and J.T., unpublished data); in both
mutations, the coding sequences for the entire catalytic domains of
both enzymes were deleted and replaced with the indicated markers.
To generate a ypk1∆ ykr2∆ double mutant, a MATα ypk1∆ strain
(YES5) was mated to a MATa ykr2∆ strain (YES1) carrying
pYKR2(URA3) (see below). The resulting diploid was subjected to
sporulation and tetrad dissection, and a His+Trp+Ura+ spore, repre-
senting a MATa ypk1∆ ykr2∆ cell kept alive with the plasmid-borne
YKR2 gene, was designated YPT28. To create the temperature-condi-
tional ypk1-1ts ykr2∆ strain, a temperature-sensitive allele was first gen-
erated by error-prone PCR amplification of YPK1 DNA [33]. The linear
PCR products were cloned by a procedure that allows for substitution
of the potentially mutant YPK1 sequences into a gapped vector, regen-
erating circular plasmids via recombination with homologous
sequences present at each end of the PCR product [53,54], and
scored for the desired phenotype by a plasmid shuffle procedure [55].
The desired mutant plasmid was recovered [56] and used to construct
a HIS3-marked derivative that was integrated in place of the chromoso-
mal YPK1 locus in a ykr2∆ strain, yielding YPT40. 
Plasmids
Plasmids for expression of PKH1, YPK1 and SGK, as GST fusions in
mammalian 293 cells, were constructed in the vector pEBG-2T [57].
Plasmids for the expression of PKH1 in yeast were constructed in
vectors YEplac195 [58] and pYES2 [59]. The vector pYES2 was used
to express PKH2 under the control of the GAL1 promoter. To express
mammalian PDK1 in yeast under the control of the PKH1 promoter, the
PKH1 promoter region was amplified by PCR, fused to a fragment
comprising the amino-terminal sequence of PDK1, and the resulting
construct used to replace the corresponding segment in plasmids con-
taining either intact PDK1, yielding YEplac195-PDK1, or a derivative of
PDK1 lacking its carboxy-terminal PH domain, yielding YEplac195-
PDK1-∆PH. The vector pYES2 was used to express genes encoding
human PDK1 and PDK1-∆PH under control of the GAL1 promoter. The
vector YEp351GAL [60] was used to express YPK1 and YKR2 in
yeast under control of the GAL1 promoter. Alternatively, an HA-tagged
version of the YPK1 coding sequence, generated by PCR, was
inserted into pYES2. A PCR-based method for precise gene fusion
[61] was used to generate a Ypk1 derivative tagged at its carboxy-ter-
minal end with the c-Myc epitope recognised by the monoclonal anti-
body 9E10 [62]. Low-copy-number (CEN) vector pRS316 [51]
carrying the URA3 gene was used to express YKR2 under control of its
endogenous promoter. Appropriate constructs to express the mam-
malian protein kinases, rat SGK, mouse PKBα, mouse p70 S6 kinase,
and bovine βARK, were constructed in the vectors, pAD4M [63] and
YEp351GAL [60], as indicated in the text. The vector pYES2 was used
to express human PKBα [24] and a constitutively active variant of
PKBα in which Thr308 and Ser473 were replaced by aspartic acid. 
Site-directed mutagenesis
To generate a catalytically inactive (kinase-dead) version of Pkh1
(Pkh1(D267A)), Asp267 was changed to Ala. This position corre-
sponds to a conserved residue critical for recognition of the Mg2+–ATP
substrate in all protein kinases [8]. Likewise, a catalytically inactive
Ypk1 derivative was generated by changing Asp488 (nucleotide
sequence GAT) to Ala (GCT). To attempt to generate a constitutively
active YPK1 derivative, the Pkh1-dependent phosphorylation site
(Thr504) and a presumptive phosphorylation site (Thr662) that
matches the consensus for phosphorylation by a PDK2-like enzyme
were replaced with aspartic acid. 
Expression and purification of GST–Pkh1, GST–Ypk1 and
GST–SGK
The 293 human embryonic kidney cell line was cultured on 40 10-cm
diameter dishes, and each dish was transfected with 20 µg of the
appropriate expression construct using a modified calcium phosphate
method [64]. Lysates were prepared and the resulting GST fusion pro-
teins were purified as described previously for GST–PKBα [3]. About
0.5 mg of each purified GST fusion protein was obtained, snap-frozen
in aliquots in liquid nitrogen and stored at –80°C.
Measurement of Ypk1, SGK and PKB activities
The assay of Ypk1 activity was carried out in two stages. First (stage 1),
GST–Ypk1 was activated by incubation with GST–Pkh1 and
Mg2+–ATP, as follows. A reaction mixture (18 µl) containing 2.5 µM
PKI, 1 µM microcystin-LR, 10 mM Mg–acetate, 100 µM unlabelled ATP
and 0.6 µM GST-Ypk1 was prepared in buffer A (50 mM Tris/HCl,
pH 7.5, 0.1 mM EGTA, and 0.1% (by vol) 2-mercaptoethanol). The
reaction was initiated by addition of 2 µl 50 nM GST–Pkh1 in buffer A
containing 1 mg/ml bovine serum albumin, and was incubated at 30°C
for 30 min. Second (stage 2), activated Ypk1 was assayed by adding
30 µl of a mixture in buffer A containing 2.5 µM PKI, 1 µM microcystin-
LR, 10 mM Mg–acetate, 100 µM [γ32P]ATP (200–400 cpm/pmol) and
100 µM crosstide (GRPRTSSFAEG in single-letter amino-acid code)
[32], a peptide phosphoacceptor substrate. After incubation for 15 min
at 30°C, the reaction was terminated by spotting a portion (45 µl) of
each reaction mixture onto small squares of phosphocellulose paper
(Whatman P81), which were washed and analysed as described [65].
Control reactions omitted either GST–Ypk1 or GST–Pkh1 and resulted
in incorporation of less than 5% of the radioactivity measured in the
presence of both of these proteins. One unit of GST–Ypk1 activity was
defined as that amount required to catalyse phosphorylation of 1 nmol
crosstide in 1 min. Assay of SGK and PKBα activities were carried out
in identical manner, except that GST–SGK and GST–PKBα, respec-
tively, replaced GST–Ypk1 in the first stage of the assay. 
Phosphorylation of GST—Ypk1, GST–PKBα and GST–SGK
by Pkh1
Incubations were identical to stage 1 of the Ypk1 assay described
above, except that [γ-32P]ATP (500–1,000 cpm/pmol) was used
instead of unlabelled ATP, and reactions were terminated by adding
SDS to a final concentration of 1%. The resulting samples were
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resolved on 7.5% SDS–polyacrylamide gels [66] and, after staining
with Coomassie blue, analysed by autoradiography. Also, the stained
band corresponding to the GST fusion protein of interest was excised
and the amount of radioactivity incorporated was quantified by liquid
scintillation counting. Ability of GST–Pkh1 to phosphorylate and acti-
vate human SGK was examined using methods identical to those
described immediately above. For phosphorylation and activation of
human PKBα by GST–Pkh1, reactions were performed in the presence
of lipid vesicles containing various 3-phosphoinositides [3], as
described in the Results. Lipid abbreviations: SA-PI(3,4,5)P3 is the D-
enantiomer of sn-1-stearoyl, 2-arachidonyl PI(3,4,5)P3; DP-PI(3,4,5)P3
is sn-1,2-dipalmitoyl D-PI(3,4,5)P3; DP-PI(3,4)P2 is sn-1,2-dipalmitoyl
D-PI(3,4)P2; DP-PI(3)P is sn-1,2-dipalmitoyl D-PI(3)P. PI(4,5)P2 was
purified from brain extract. 
Determination of Ypk1 substrate specificity 
GST–Ypk1 was activated with Pkh1 in vitro and incubated under stan-
dard assay conditions, as described above, except that crosstide was
replaced by 100 µM of the peptides discussed in detail in the Results.
GST–PKBα and GST–SGK, activated by phosphorylation with PDK1
in vitro were assayed in parallel.
Supplementary material
A figure showing the in vivo Pkh1-dependent phosphorylation of Ypk1,
a table of the yeast strains used in this study and additional method-
ological details are published with this paper on the internet.
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Supplementary materials and methods
Cell culture
S. cerevisiae strains used are described in Table S1, and were derivatives
of either AYS927 (W303 background) or YPH499 (S288C background).
Yeast was grown at 30°C in a rich medium (YPD) containing 1% yeast
extract, 2% peptone (Difco) and 2% glucose, or in a synthetic minimal
medium (S), containing either galactose (Gal), raffinose (R) or glucose
(Glc, or D, for dextrose) as the carbon source, supplemented with nutri-
ents appropriately to maintain selection for markers and plasmids [S1].
Standard methods were used for yeast genetic manipulation [S1,S2] and
for plasmid construction and propagation in Escherichia coli [S3].
Recombinant DNA techniques
Restriction enzyme digests, DNA ligations and other recombinant DNA
procedures were performed as described [S3]. Modification of the
Li–acetate procedure was used for yeast transformation [S4]. PKH1 and
PKH2 genes used in this study, and the YPK1 gene in some construc-
tions, were recovered from genomic DNA of strain AYS927 using PCR
amplification, gel-purified, and cloned first into the pCR2.1-TOPO vector
(Invitrogen). Site-directed mutagenesis was performed using the
QuikChange Kit (Stratagene) following instructions provided by the man-
ufacturer. DNA constructs were verified by automatic DNA sequencing
using an automated DNA Sequencer (Model 373; Applied Biosystems).
PCR amplification of yeast genomic DNA 
The primers used to amplify the PKH2 coding region were 5′-
CGGGATCCGCCACCATGGAGCAGAAGCTGATCTCTGAAGAGG
ACTTGTATTTGATAAGGATAATTCCATG-3′ (forward) and 5′-ATAA-
GAATGCGGCCGCTTACGACCTCTTCGATTTTGCAG-3′ (reverse),
and incorporated BamHI and NotI sites, respectively (indicated by
italics). The primers used to amplify the PKH1 coding region were 5′-
ATAAGAATGCGGCCGCTGCCACCATGGAGCAGAACCTGTCTCT
GAAGAGGACTTGGGAAATAGGTCTTGACAGAGG-3′ (forward)
and 5′-ATAAGAATGCGGCCGCTCATTTTTCATCTGTCCGTGTC-3′
(reverse), and incorporated NotI sites (indicated in italics). Both 5′
primers also contained a sequence encoding a 10-residue c-Myc
epitope tag (underlined). The primers used to amplify the YPK1 gene
were: 5′-GGATCCGCCACCATGTACCCATACGATGTGCCAGAT-
TACGCCTATTCTTGGAAGTTTAAG-3′ (forward) and 5′-GGTACCC-
TATCTAATGCTTCTACCTTGC-3′ (reverse), and incorporated BamHI
and KpnI restriction sites, respectively (italics). The initiator or termina-
tion codons in all these primers are also indicated (bold type). 
PCR-based gene disruptions and strain constructions
To generate the pkh2∆::HIS3 mutation, HIS3 was amplified from
pRS313 [S5] using as primers 5′-AAGTAACATCTTGATGAACCGA-
GAAGCCACTAACTAGTTTTGTGCACCATAATTTTCCG-3′ (forward),
where the underlined sequence corresponds to nucleotides –93 to
–53 from the PKH2 initiator codon and the remainder of the primer cor-
responds to nucleotides –326 to –311 from the initiator codon of
HIS3, and 5′-TAAGTAGCTTGATGAAAACATTAGATAAAATTACTAA-
TTACCGTCGAGTTCAAGAG-3′, (reverse) where the underlined
sequence corresponds to the nucleotides immediately after the PKH2
stop codon (in bold type) and the remainder corresponds to
nucleotides 204–189 after the HIS3 stop codon. The resulting 3.3 kb
product was used for DNA-mediated transformation of a diploid strain
(AYS927). Transformants were selected on SD-His plates, and disrup-
tion was verified by PCR analysis of DNA from one of the His+ isolates
using appropriate primers. This heterozygous PKH2/pkh2∆::HIS3
diploid (AC200) was sporulated, and the resulting tetrads were dis-
sected. Spore clones were analysed by plating on selective medium
and confirmed by PCR to identify a haploid containing the
pkh2∆::HIS3 disruption (AC303). To generate the pkh1∆::TRP1 muta-
tion, the TRP1 marker in pRS314 [S5] was amplified using 5′-
GCACGTGTACTTGCTTGAATACTGCTACTATATCATTAATATGGTA
CTGAGAGTGCACC-3′ (forward), where the underlined sequence
corresponds to nucleotides immediately upstream of the initiator codon
(bold type) and the remainder corresponds to nucleotides situated
–300 to –285 nucleotides from the initiator codon of TRP1, and 5′-
TATTATGCATTACACTTTCCCCTTCACCATGTCTTACATATGCATC-
CGCAGGCAAGTGCAC-3′ (reverse), where the underlined
nucleotides correspond to positions +69 to 25 after the PKH1 stop
codon and the remainder of the primer corresponds to the region situ-
ated +51 to 36 nucleotides after the TRP1 stop codon. The resulting
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Figure S1
Phosphorylation of Ypk1 in vivo is dependent on Pkh1. Haploid strains
AC301 (pkh1∆) and AC303 (pkh2∆), and their otherwise isogenic
parent (wt), were transformed, as indicated, with either a vector
expressing YPK1 or the same vector expressing Ypk1 tagged with a
c-Myc epitope (YPK1m) and metabolically labelled with [32P]PO43–.
Whole-cell extracts were prepared, clarified, and then subjected to
immunoprecipitation with mouse anti-c-Myc monoclonal antibody
9E10. After extensive washing, duplicate samples of the
immunoprecipitates were solubilised, subjected to SDS–PAGE,
transferred to a PVDF membrane, and analysed by autoradiography to
measure 32P incorporated (upper panel) and by immunoblotting with
the anti-Myc monoclonal antibody (lower panel) to assess the relative
recovery of Ypk1–Myc in each sample. 
Ypk1–Myc
Strain wt pkh1∆ pkh2∆wt
Plasmid YPK1 YPK1m YPK1m YPK1m
Ypk1–Myc
97 kDa
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2.4 kb product was used for transformation of AYS927, and transfor-
mants were selected on SD-Trp plates. Disruption was verified by PCR
analysis from one of the Trp+ isolates using appropriate primers. This
heterozygous diploid PKH1/pkh1∆::TRP1 (AC201) was sporulated,
dissected, analysed, and a haploid spore containing the pkh1∆::TRP1
mutation (AC301) was identified.
Generation of the ypk1-1ts ykr2∆ strain 
To create the temperature-conditional ypk1-1ts ykr2∆ strain (YPT40), a
temperature-sensitive allele of YPK1 was first generated, as follows. A
genomic insert containing the YPK1 gene cloned into the XbaI site in
the vector, pGEM3TM (Promega), and generously provided by Richard
A. Maurer (then at the University of Iowa) [S6], was excised as a 4.1 kb
XbaI–SalI fragment and inserted into the LEU2-containing vector,
pRS315 [S5], yielding pRS315-YPK1. The sequence encoding the
catalytic domain of YPK1 was then amplified under moderately error-
prone conditions using AmpliTaqTM DNA polymerase (Perkin Elmer
Cetus), with pRS315-YPK1 as the template and a 5′ primer (P1), 5′-
TGCCCTCGAAGACATGGC-3′, corresponding to a sequence begin-
ning at nucleotide 788 (where the first base of the ATG start codon is
+1) and a 3′ primer (P2), 5′-CTTGAACACAGTAAGTAACGG-3′, cor-
responding to the flanking genomic sequence commencing 68 bp
downstream of the stop codon. The resulting 1350 bp linear PCR
product was gel-purified and co-transformed into a haploid ypk1∆
ykr2∆ double mutant carrying pYKR2(URA3) (strain YPT28) along with
a ~9 kb linear fragment of pRS315-YPK1, that had been generated by
digestion with PstI and NcoI, and gel-purified. Transformants were
selected on SCD-Leu plates at 26°C. This procedure allows for
replacement of the corresponding sequence in the parent vector with
potentially mutant sequences, and regeneration of circular plasmids, via
in vivo repair of the gapped plasmid by recombination with homolo-
gous sequences present at each end of the PCR product [S7,S8]. 
To determine which LEU2-containing plasmids expressed functional
YPK1 at 26°C, the Leu+ transformants were subsequently replica-plated
onto Leu– plates containing 5-FOA to select for loss of the
pYKR2(URA3) plasmid initially present in YPT28. To determine which of
the YPK1- and LEU2-containing plasmids harboured a temperature-sen-
sitive allele of YPK1, the Leu+ Ura– cells were tested by replica-plating
for their ability to grow on SCD-Leu plates at 37°C. One transformant
was identified that reproducibly failed to grow at this temperature. The
LEU2-containing plasmid carried by this strain (pypk1TS) was recovered
[S9], and direct nucleotide sequence analysis of the YPK1 open reading
frame in the plasmid revealed the presence of two amino acid substitu-
tions (I484T and Y536C). Subcloning and re-transformation confirmed
that these mutations were sufficient to confer the temperature-sensitive
(ts) phenotype, and this allele was designated ypk1-1ts. The ypk1-1ts
allele was used to transplace the normal YPK1 chromosomal locus in
the ykr2∆ strain (YES1), as follows. First, PCR was used to generate a
customised DNA fragment containing BamHI and SmaI restriction sites
96 and 108 bp, respectively, downstream from the stop codon of the
YPK1 coding sequence in pypk1TS plasmid, and this fragment was sub-
stituted for the corresponding segment of the 3′-flanking region, yielding
pINT. A 2.6 kb ScaI–BamHI fragment containing the HIS3 gene, excised
from vector, pRS303 [S5], was gel-purified and inserted into pINT that
had been digested with BamHI and SmaI, yielding pINT-HIS, which was
able to confer both leucine and histidine prototrophy to a leu2 his3
strain, YPH499 [S5]. Finally, a 4.6 kb ClaI–XhoI fragment from pINT-HIS,
containing the ypk1-1ts allele, the HIS3 gene, and additional genomic
DNA from the YPK1 locus flanking the HIS3 gene to its 3′-side, was gel-
purified and used for transformation of YES1. His+ transformants were
selected at 26°C, The presence of the integrated ypk1-1ts allele (and the
absence of the normal YPK1 locus) was then confirmed by PCR analysis
of DNA isolated from the transformants and by demonstrating that such
cells were unable to grow at 37°C. One such isolate that met all of these
criteria was designated strain YPT40. 
Plasmids
For expression of PKH1 and YPK1 as GST fusions in mammalian 293
cells, the corresponding coding sequences were excised from the
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Table S1
S. cerevisiae strains used in this study.
Strain Genotype Source
AYS927 MATa/MATα ade2-1/ade2-1 his3-11,15/his3-11,15 M.J.R. Stark 
leu2-3,112/leu2-3,112 trp1-1/trp1-1 ura3-1/ura3-1
can1-100/can1-100 ssd1-d2/ssd1-d2
AC200 AYS927 PKH2/pkh2∆::HIS3 This study
AC201 AYS927 PKH1/pkh1∆::TRP1 This study
AC303 MATa pkh2∆::HIS3 (derived from AC200) This study
AC301 MATα pkh1∆::TRP1 (derived from AC201) This study
AC306 MATa/MATα PKH1/pkh1∆::TRP1 PKH2/pkh2∆::HIS3 This study
(AC303 X AC301)
YPH499 MATa ade2-101oc his3-∆200 leu2-∆1 lys2-801am [S5] 
trp1-∆1 ura3-52
YPH500 MATα otherwise isogenic to YPH499 [S5]
YES1 YPH499 ykr2-∆1::TRP1 This study
YES5 YPH500 ypk1-∆1::HIS3 This study
YES7 MATa/MATα YPK1/ypk1∆::HIS3 YKR2/ykr2∆::TRP1 This study
(YES1 X YES5)
YPT28 MATa ypk1∆::HIS3 ykr2∆::TRP1 [pYKR2(URA3)] This study
YPT40 MATa ypk1-1ts ykr2∆ This study
appropriate pCR2.1-TOPO derivative and inserted into the mammalian
expression vector, pEBG-2T [S10]. PKBα [S11], PDK1 [S12] and
SGK (lacking its amino-terminal 60 residues) [S13] were subcloned
into the pEBG-2T vector as described. For expression of PKH1 in
yeast, a 2.1 kb fragment, from an internal SmaI site (situated about
250 bp downstream from the initiator codon) to an EcoRI site in the
pCR2.1-TOPO vector, was first inserted into the 2 µm DNA vector,
YEplac195 [S4], that had been digested with SmaI and EcoRI, yielding
YEplac195-2.1PKH1. To restore the 5′ end, a 1 kb fragment was
amplified by PCR using the primers 5′-GCTTGACTCAATTAAGGC-
GAC-3′ (forward), corresponding to nucleotides 628–634 upstream of
the initiator codon, and 5′-ACATGCTTAGTTAACTCC-3′ (reverse),
corresponding to the region located 350 bp downstream of the initiator
codon. The resulting product was first cloned into pCR2.1-TOPO,
which was then digested with SmaI and SphI to liberate a 0.9 kb frag-
ment that was inserted into the YEplac195-2.1PKH1 construct that
had been digested with SphI and SmaI, yielding YEplac195-PKH1,
which contains the complete coding region of the PKH1 gene plus
0.5 kb of its promoter region and carries the URA3 gene as the selec-
table marker. To express PKH1 under control of the GAL1 promoter, a
2.3 kb NotI–NotI fragment containing the Myc-tagged version of the
entire PKH1 coding sequence was inserted into the URA3-marked,
2 µm DNA-containing vector, pYES2 [S14], yielding pYES2-PKH1.
Likewise, to express PKH2 under GAL1 promoter control, a 3.3 kb
BamHI–NotI fragment containing the entire PKH2 open reading frame
was inserted into pYES2, yielding pYES2-PKH2.  
To express mammalian PDK1 in yeast under control of the PKH1 pro-
moter, a 0.7 kb fragment corresponding to the PKH1 promoter region
was first amplified by PCR from the YEplac195-PKH1 construct using
the primers 5′-GGGGTACCGCTTGACTCAATTAAGGCGAC-3′
(forward) and 5′-CTTCAGAGATCAGCTTCTGCTCCATATTAAT-
GATATAGTA-3′ (reverse), corresponding to the start of the PDK1
coding sequence (underlined). Second, a 1.4 kb fragment comprising
the amino-terminal sequence of PDK1 was amplified from a human
PDK1 cDNA using as primers the 0.7 kb PCR amplification product
(forward) and 5′-ACACGATCTCAGCCGTGTAAA A-3′(reverse), cor-
responding to residues 190–184 of PDK1. The 1.4 kb product was
cleaved at the KpnI site (italics) and also with HindIII, which cleaves at
an internal site in the PDK1 coding sequence. The resulting
KpnI–HindIII fragment was used to replace a 0.5 kb segment encoding
the amino-terminal end of the PDK1 protein either in a construct con-
taining the complete PDK1 coding sequence, yielding YEplac195-
PDK1, or in a construct containing just the first 404 residues of the
PDK1, corresponding to its catalytic domain and lacking its carboxy-
terminal PH domain, generating YEplac195-PDK1-∆PH. To express
human PDK1 under control of the GAL1 promoter, a 2.0 kb BglII–XbaI
fragment containing the complete PDK1 coding sequence was
inserted into pYES2, yielding pYES2-PDK1. Similarly, a 1.4 kb
BglII–XbaI fragment containing the kinase domain of PDK1, but lacking
the PH domain, was inserted into pYES2, creating pYES2-PDK1-∆PH.
To express YKR2 in yeast from a LEU2-marked, high-copy-number
(2 µm DNA-based) plasmid under control of the GAL1 promoter, a
2.4 kb XhoI–HindIII fragment of genomic DNA containing the entire
YKR2 open reading frame [S15] was excised from an insert in pUC18
(generously provided by Shigeo Ohno, Department of Molecular
Biology, Tokyo Metropolitan Institute of Medical Science, Tokyo) and
ligated into the vector, YEp351GAL [S16], that had been linearised by
digestion with SalI and HindIII, yielding pGAL-YKR2. An essentially
identical approach was used to express YPK1, excised from a genomic
DNA fragment (see above), yielding pGAL-YPK1, which was con-
structed by Henrik Dohlman (Thorner laboratory). Alternatively, a 2.1 kb
BamHI-NotI fragment encoding an HA-tagged version of the YPK1
coding sequence, generated by PCR, was inserted into pYES2, yield-
ing pYES2-YPK1. To place the YKR2 gene under control of its
endogenous promoter on a low-copy-number (CEN) plasmid carrying
the URA3 gene, a 2.5 kb EcoRI–EcoRI fragment of the original YKR2-
containing insert in pUC18 was ligated into the vector, pRS316 [S5],
that had been linearised with EcoRI, generating pYKR2(URA3). To
generate a version of Ypk1 tagged at its carboxyl terminus with the c-
Myc epitope recognised by the monoclonal antibody 9E10 [S17], a
PCR-based method for precise gene fusion [S18] was performed
using the YPK1 sequence cloned in pGEM3 as one template, and, as
the other template, a sequence encoding the 16-residue version of the
Myc epitope followed by a His6 tag cloned in pBluescript (Stratagene),
generously provided by Elana Swartzman (Thorner laboratory), and
three appropriate synthetic oligonucleotide primers: P1; T3 (Strata-
gene), 5′-AATTAACCCTCACTAAAGGG-3′, corresponding to
sequences in the pBluescript vector; and, a ‘joiner’ primer (P3), 5′-
TTCAGAAATCAACTTTTGTTCTCTAATGCTTCTACCTTGC-3′, corre-
sponding to the 3′-end of the YPK1 coding sequence and the first
several residues of the c-Myc epitope. A 2 kb ClaI–SalI fragment of the
resulting product was used to replace the corresponding segment in
the original YPK1-containing pGEM3 vector [S6], yielding pYPK1myc.
A 1.2 kb NcoI–HindIII fragment of pYPK1myc was used to replace the
corresponding segment of pGAL-YPK1, yielding pGAL-YPK1myc. 
To express SGK in yeast, a 1.3 kb NcoI–EcoRI fragment encoding a rat
SGK cDNA [S19] (generously provided by Gary Firestone, Department
of Molecular and Cell Biology, University of California, Berkeley, Califor-
nia) was converted to blunt ends by treatment with the Klenow frag-
ment of E. coli DNA polymerase I in the presence of dNTPs and
inserted behind the ADH1 promoter in the vector pAD4M [S20] that
had been linearised with SmaI. Correct orientation of the fragment was
confirmed by appropriate restriction enzyme digests. An essentially
identical approach was used to express bovine βARK, yielding pADH-
βARK, which was constructed by Henrik Dohlman (Thorner laboratory).
To express PKB in yeast, a 1.5 kb BamHI–BamHI fragment encoding
mouse c-Akt was excised from an insert in a two-hybrid bait vector,
pASIIA (supplied by Zhou Songyang, Department of Biology, Massa-
chusetts Institute of Technology, Cambridge), and ligated into
YEp351GAL that had been linearised by digestion with BamHI, yielding
pGAL-PKB. Alternatively, a 2.5 kb EcoRI–XbaI fragment encoding a
human PKBα cDNA [S21] was inserted into pYES2, generating
pYES2-PKBα. In addition, a 1.5 kb EcoRI–XbaI insert expressing a con-
stitutively active mutant version of PKBα [S22], in which Thr308 and
Ser473 have been replaced by aspartic acid residues, was inserted into
pYES2, creating pYES2-DD-PKBα. To express p70 S6K in yeast, a
1.6 kb XbaI–SalI fragment encoding rat p70 S6K [S23] was excised
from p2B4 (kindly provided by George Thomas, Friedrich Miescher
Institute, Basel, Switzerland) and inserted into YEp351GAL that had
been linearised by digestion with XbaI–SalI, yielding pGAL-S6K. In
addition, an amino-terminal truncation, a carboxy-terminal truncation,
and a double amino- and carboxy-terminal truncation of p70 S6 kinase
(generously provided by John Blenis, Department of Cell Biology,
Harvard Medical School, Boston), whose constructions are described
in detail elsewhere [S24], were also inserted into a yeast expression
vector, YEp352 [S25], each under control of the methionine-repress-
ible MET3 promoter [S26] using essentially identical methods.
Plasmid pPKH1-HA was constructed by PCR as follows: Primers 
5′-TGCGCTCGAGATGGGAAATAGGTCTTTG-3′ (underlined bases
correspond to an introduced XhoI site, and start codon in italics) and
5′-CGCATGCATTAGCGGCCGCCTTTTTCATCTGTCCGTG-3′
(underlined bases correspond to an introduced NsiI site, italic bases
the stop codon, and bold bases correspond to an introduced NotI site)
were used to amplify the entire open reading frame of PKH1 from
pYES2-PKH1. This 2.2 kb PCR fragment was then digested with XhoI
and NsiI and ligated into vector YEp351GAL that had been digested
with SalI and PstI. The resulting plasmid, pPKH1, contained a NotI site
just before the stop codon to permit in-frame insertion of a fragment
encoding three tandem HA epitope tags, which were excised as a NotI
fragment from a plasmid described elsewhere [S27]. Orientation of the
tag was confirmed by sequencing. Plasmid pPKH2-HA was con-
structed by PCR in a very similar manner, using primers 5′-
TGCGGGATCCATGTATTTTGATAAGGATAAT-3′, (underlined bases
correspond to an introduced BamHI site, start codon in italics) and 
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5′-CCGCTCGAGTTAGCGGCCGCCCGACCTCTTCGATTTTG-3′
(underlined bases correspond to an introduced XhoI site, italic bases the
stop codon, and bold bases correspond to an introduced NotI site) to
amplify the entire open reading frame of PKH2 from pYES2-PKH2. The
3.2 kb PCR fragment was then digested with BamHI and XhoI and ligated
to vector YEp351GAL that had been digested with BamHI and SalI.
Radiolabeling of yeast cells and immunoprecipitation of Ypk1
from cell extracts
Yeast strains harbouring pGAL-YPK1myc were grown at 30°C to mid-
exponential phase in raffinose-containing minimal medium, supple-
mented with all L-amino acids and nucleotides (except Leu and Ura).
The cells were collected, diluted into galactose-containing low phos-
phate medium [S28], grown to mid-exponential phase, collected, con-
centrated 10-fold and incubated for 2.5 h with 0.5–1 mCi of 32PO43–.
Radiolabeled cells were collected by brief sedimentation in a clinical
centrifuge, washed with PBS and resuspended in ice-cold extraction
buffer containing a mixture of phosphoprotein phosphatase inhibitors
and protease inhibitors that has been described [S29]. Extracts were
prepared and Ypk1–Myc protein was immunoprecipitated with the
9E10 anti-c-Myc monoclonal antibody, according to methods
described in detail elsewhere [S30]. The final washed immune com-
plexes were resuspended in 15 µl SDS–PAGE sample buffer, and
heated to 90°C for 5 min. Samples were clarified by centrifugation for
2 min in a microfuge, and the supernatant solution (typically ~25 µl)
was subjected to electrophoresis on a 8% polyacrylamide gel in the
presence of SDS. Autoradiography of dried gels or PVDF filter repli-
cas was performed using either X-ray film or a Phosphorimager
(StormTM; Molecular Dynamics), according to procedures recom-
mended by the manufacturer. 
Antisera
A rabbit polyclonal anti-Ypk1 antiserum (#1446) was raised against a
GST–Ypk1 fusion protein containing the first 115 residues of Ypk1,
expressed in and purified from E. coli. For immunoblotting, the anti-
serum was used at 1:3,000 dilution. Other antisera used in this study
were the gifts of other investigators.
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